Redona Therapeutics

Watertown, United States

Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases.

$60.8M raised

Jul 2023

Venture - Series Unknown

Health Care Health Diagnostics Medical

Top Investors

Astellas Venture Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Redona Therapeutics

How much funding has Redona Therapeutics raised?

Redona Therapeutics has raised $60.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.

Who are Redona Therapeutics's investors?

Redona Therapeutics's investors include Astellas Venture Management.

Where is Redona Therapeutics headquartered?

Redona Therapeutics is headquartered in Watertown, United States.

What does Redona Therapeutics do?

Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases.

What stage is Redona Therapeutics at?

Redona Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 31, 2023.

MLA

"Redona Therapeutics — Funding & Investors." VCBacked, July 31, 2023, https://www.vcbacked.co/company/redona-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Redona Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/redona-therapeutics

Wikipedia (cite web)

{{cite web |title=Redona Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/redona-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 31, 2023.